Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ekuQCfbwocfCbayxgGwZ

  ADVERTISEMENT  
February 18, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
 
  • Hospitals join patient safety initiative
    More than 20 hospitals and hospital groups have committed to actions that will increase patient safety, while nine medical device firms will make patient information more accessible, according to the Patient Safety, Science & Technology Movement. The action plans include goals linked to the prevention of catheter line-associated bloodstream infections, as well as pledges involving education about blood transfusions and proper blood management. BeckersHospitalReview.com (2/15) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
How much do you hate your anti-Fyb?
Tired of sub-par reactions? Quotient has a newly approved anti-Fyb, as well as hard-to-find Anti-s, Anti-Wra and other rare antisera that are worth a try. Find out how the one company focused on manual testing can serve you in 2013 and beyond.

  Science & Health 
  • CDC: Flu activity continues downward trend
    CDC data from the week ending Feb. 9 showed that flu activity in many states continued to drop. Eleven states and New York City reported high levels of flu activity, and 10 states reported moderate activity. Adults aged 65 and older account for more than half of total flu-related hospitalizations, and 64 children have died so far this flu season, the CDC said. DoctorsLounge.com/HealthDay News (2/15) LinkedInFacebookTwitterEmail this Story
  Hot Topics 

Top five news stories selected by AABB SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Emerging Trends 
  • Students see potential for vaccine-delivering mosquitoes
    Provita, a company operated by science- and business-oriented high school students, is developing a "flying syringe" approach to managing mosquito-born diseases. The company hopes to develop mosquitoes that can produce a West Nile virus vaccine. The company also is working on a product called Coagula intended to reduce the need for injections to treat von Willebrand disease and hemophilia. FastCoExist (2/15) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • Group issues assessment to gauge hospital safety, quality
    The Institute for Safe Medication Practices has introduced the 2011 ISMP Medication Safety Self Assessment for Hospitals meant to help health care facilities evaluate drug practice safety, pinpoint improvement opportunities and compare outcomes with similar hospitals. BeckersASC.com (2/15) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • FDA accelerates review of ViiV's HIV/AIDS drug dolutegravir
    ViiV Healthcare, a joint venture of GlaxoSmithKline, Pfizer and Shionogi, obtained priority-review status from the FDA for its investigational daily HIV/AIDS treatment dolutegravir. The drug is an integrase inhibitor that keeps HIV out of cells. The FDA is set to decide on the drug's approval by Aug. 17. Yahoo/Reuters (2/16) LinkedInFacebookTwitterEmail this Story
  Association News 
  • (CT) AABB Center for Cellular Therapies to develop directory of training opportunities
    The AABB Center for Cellular Therapies is seeking contributions to develop a directory of training opportunities. Upon completion, the directory will offer members a comprehensive list of education programs related to cellular therapy laboratory practice, quality activities, patient care and clinical programs. All organizations offering such opportunities are encouraged to complete the online submission form. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Donor Collections DirectorBlood Centers of the PacificUS - CA - San Francisco
Medical Technologist CLS - Cord Blood ProgramSan Diego Blood BankUS - CA - San Diego
Click here to view more job listings.

  SmartQuote 
You will become as small as your controlling desire; as great as your dominant aspiration."
--James Allen,
British author


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Jennifer Garfinkel

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information